LYEL
NASDAQ · Biotechnology
Lyell Immunopharma Inc
$20.89
+1.19 (+6.04%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+33.8% upside
Low Target
$18.45
Average Target
$27.95
High Target
$35.39
Current Price
$20.89
Current
$20.89
$20.89
Target
$27.95
$27.95
$18.45
$27.95 avg
$35.39
Scenario Analysis
Bear Case
$18.45
-11.7%
Low target
Base Case
$27.95
+33.8%
Avg target
Bull Case
$35.39
+69.4%
High target
Risk/Reward
5.9x
Highly favorable
Price in Context
52-Week High
$45.00
-53.6% from high
52-Week Low
$7.65
+173.1% from low
Target vs 52W High
$27.95
-37.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |